Qi Guo

361 Zhongshan East Road
Shijiazhuang, 050017, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 53 publications

Corrigendum to "Piezo1 activation mediates stiffness-induced aortic medial calcification: Pharmacological evidence from agonist and antagonist studies" [Eur. J. Pharmacol. 1011 (2026) 178465].

Corrigendum to "Piezo1 activation mediates stiffness-induced aortic medial calcification: Pharmacological evidence from agonist and antagonist studies" [Eur. J. Pharmacol. 1011 (2026) 178465].

Journal: European journal of pharmacology

Published: June 27, 2026

Trimethylamine N-oxide drives cardiac aging by activating NLRP3-mediated pyroptosis.

Trimethylamine N-oxide drives cardiac aging by activating NLRP3-mediated pyroptosis.

Journal: Life sciences

Published: March 26, 2026

Construction of a Double Covalent-Network Structured Superhydrophobic Composite Coating with Mechanochemical Robustness and Self-Cleaning Property.

Construction of a Double Covalent-Network Structured Superhydrophobic Composite Coating with Mechanochemical Robustness and Self-Cleaning Property.

Journal: Langmuir : the ACS journal of surfaces and colloids

Published: February 13, 2026

Hydrogen sulfide improves vascular endothelial function in hypertensive states through SIRT6 anti-inflammatory signaling.

Hydrogen sulfide improves vascular endothelial function in hypertensive states through SIRT6 anti-inflammatory signaling.

Journal: Acta biochimica et biophysica Sinica

Published: November 25, 2025

Pioneering Insights into the Complexities of Salt-Sensitive Hypertension: Central Nervous System Mechanisms and Dietary Bioactive Compound Interventions.

Pioneering Insights into the Complexities of Salt-Sensitive Hypertension: Central Nervous System Mechanisms and Dietary Bioactive Compound Interventions.

Journal: Nutrients

Published: November 01, 2025

Piezo1 activation mediates stiffness-induced aortic medial calcification: Pharmacological evidence from agonist and antagonist studies.

Piezo1 activation mediates stiffness-induced aortic medial calcification: Pharmacological evidence from agonist and antagonist studies.

Journal: European journal of pharmacology

Published: August 11, 2025

Trimethylamine N-oxide induces cardiac diastolic dysfunction by down-regulating Piezo1 in mice with heart failure with preserved ejection fraction.

Trimethylamine N-oxide induces cardiac diastolic dysfunction by down-regulating Piezo1 in mice with heart failure with preserved ejection fraction.

Journal: Life sciences

Published: November 20, 2024

Hydrogen sulfide preserves the function of senescent endothelium through SIRT2 mediated inflammatory inhibition.

Hydrogen sulfide preserves the function of senescent endothelium through SIRT2 mediated inflammatory inhibition.

Journal: Journal of molecular and cellular cardiology

Published: October 18, 2024

Hydrogen sulfide attenuates sepsis-induced cardiac dysfunction in infant rats by inhibiting the expression of cold-inducible RNA-binding protein.

Hydrogen sulfide attenuates sepsis-induced cardiac dysfunction in infant rats by inhibiting the expression of cold-inducible RNA-binding protein.

Journal: Bioscience reports

Published: October 16, 2024

Evaluation of the Tellurium Dioxide Crystal Shear Acoustic Wave Attenuation at 40-140 MHz Frequency.

Evaluation of the Tellurium Dioxide Crystal Shear Acoustic Wave Attenuation at 40-140 MHz Frequency.

Journal: Materials (Basel, Switzerland)

Published: July 26, 2024

Butyrate attenuates sympathetic activation in rats with chronic heart failure by inhibiting microglial inflammation in the paraventricular nucleus.

Butyrate attenuates sympathetic activation in rats with chronic heart failure by inhibiting microglial inflammation in the paraventricular nucleus.

Journal: Acta biochimica et biophysica Sinica

Published: June 12, 2024

Hydrogen Sulfide Ameliorates Heart Aging by Downregulating Matrix Metalloproteinase-9.

Hydrogen Sulfide Ameliorates Heart Aging by Downregulating Matrix Metalloproteinase-9.

Journal: Cardiovascular drugs and therapy

Published: May 21, 2024

Showing 1-12 of 53

Last Updated: 09/26/2026